Lipaglyn (Saroglitazar) for Treating Hypertriglycerdemia in Type II Diabetes
Lipaglyn (Saroglitazar) is a dual peroxisome proliferator-activated receptor (PPAR) agonist indicated for the...
Trending menu:
-
![Digital Research]()
Scientist.com and Austrade to expand digital research marketplace in Australia
-
![]()
Elligo Health unveils new clinical trials technology
-
![]()
Olumiant (baricitinib) for the Treatment of Moderate-to-Severe Rheumatoid Arthritis
-
![]()
Cabometyx (cabozantinib) for Treatment of Patients with Advanced Renal Cell Carcinoma
-
![]()
Keytruda (pembrolizumab) for the Treatment of Metastatic Melanoma
-
![]()
Tremfya (guselkumab) for the Treatment of Plaque Psoriasis
Most Read
- Celltrion implements Veeva Vault eTMF to improve visibility into clinical trial activities
- Parexel launches integrated FPS model to drive delivery of clinical research partnerships
- Medable unveils telemedicine solution only for clinical trials
- Broader inclusion criteria to double eligible cancer patients for clinical trials, finds study
- Find out how pharma is fighting respiratory illnesses in the latest Pharma Technology Focus
Company A-Z
Latest Content
ClinOne and Boston Children’s Hospital partner for trial enhancement
ClinOne has launched its eConsent with Video eConsent technology in collaboration with Boston Children’s Hospital (BCH).
October’s top news stories
GSK has initiated the Phase III EAGLE programme of gepotidacin for the treatment of uncomplicated urinary tract infection and urogenital gonorrhoea, and AstraZeneca has reported that a combination of Imfinzi with chemotherapy improved progression-free survival (PFS) in the ongoing Phase III POSEIDON trial in non-small cell lung cancer (NSCLC). Clinicaltrialsarena.comwraps up key headlines from October 2019.
TrialAssure launches document anonymisation tool using AI
Clinical trial transparency tools provider TrialAssure has launched new software called Anonymize R.
Mednet and Bioforum partner to optimise efficiency of clinical trials
Global eClinical solutions provider Mednet and data-focused contract research organisation (CRO) Bioforum have formed a strategic partnership to optimise the efficiency and flexibility of clinical trials.
Clinerion and PPC join forces on clinical trials acceleration
Clinical research services provider Clinerion has partnered with PPC to offer Patient Network Explorer services in South Korea, China and Taiwan.
Malvern Panalytical’s Zetasizer Ultra to Speed-Up and Simplify Workflow
Dolomite Microfluidics, based in Royston, UK, is a brand of Blacktrace Holdings Ltd, a company which develops and manufactures groundbreaking technologies for applications in biology, chemistry, microfluidics and nanomaterials.
Gilead and Glympse partner on biomarker technology use
US antiviral drugmaker Gilead Sciences has formed a strategic collaboration with Glympse Bio to explore the use of biomarker technology in nonalcoholic steatohepatitis (NASH) clinical development.
Manufacturers Choose the Mastersizer 3000 for Accuracy and Efficiency
In 2016, Metals and Additives LLC, a leading manufacturer and supplier of powder additives for the battery and plastics industries, purchased the Mastersizer 3000 from Malvern Panalytical.
AtreMorine for Parkinson’s Disease and Dopamine-Related Disorders
AtreMorine is a novel biopharmaceutical compound obtained through non-denaturing biotechnological procedures from the structural components of the Vicia faba L plant, for the prevention and treatment of Parkinson´s disease (PD) and related disorders.
Worldwide selects ClinSpark eSource platform to automate trials
Worldwide Clinical Trials has implemented Foundry Health’s ClinSpark eSource Platform to automate Phase I first-in-human clinical trials for clinical development.
Latest News
Close
Close
Close
Go Top
